Effects of single administration of morphine on G-protein mRNA level in the presence and absence of inflammation in the rat spinal cord

Scandinavian Journal of Immunology

Volumn 67, Issue 1, 2008, Pages 47-52

  Askari, N ^a   Mahboudi, F ^b   Haeri Rohani, A ^a   Kazemi, B ^c   Sarrami, R ^b   Edalat, R ^b   Ahmadiani, A ^c  

^a UNIVERSITY OF TEHRAN   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MORPHINE SULFATE; NALOXONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; GENE EXPRESSION; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD;

ANALGESICS, OPIOID; ANIMALS; CARRAGEENAN; DRUG ADMINISTRATION SCHEDULE; GTP-BINDING PROTEINS; INJECTIONS, INTRAPERITONEAL; MALE; MORPHINE; MYELITIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPINAL CORD;

EID: 36749031206     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02043.x     Document Type: Article

References (29)

1. Kayser V, Guilbaud G. The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats. Brain Res 1983 267:131 8.
2. Stein C, Millan MJ, Yassouridis A, Herz A. Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism. Eur J Pharmacol 1988 155:255 64.
3. Fechoa K, Manningb EL, Maixnerb W, Schmittd CP. Effects of carrageenan and morphine on acute inflammation and pain in Lewis and Fischer rats. Brain Behav Immun 2007 21:68 78.
4. Stanfa LC, Dickenson AH. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation. Br J Pharmacol 1993 108:967 73.
5. Kieffer BL, Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol 2002 66:285 306.
6. Hildebrandt JD. Role of subunit diversity in signaling by heterotrimeric G proteins. Biochem Pharmacol 1997 54:325 39.
7. Tailor DA, Fleming WW. Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 2001 297:11 8.
8. Hepler JR, Gilman AG. G proteins. Trends Biochem Sci 1997 17:561 71.
9. Clapham DE, Neer EJ. G protein βγ subunits. Annu Rev Pharmacol Toxicol 1997 37:167 203.
10. Parolaro D, Patrini G, Giagnoni G, Massi P, Groppetti A, Parenti M. Pertossis toxin inhibits morphine analgesia and prevents opiate dependence. Pharmacol Biochem Behav 1990 35:137 41.
11. Crain SM, Shen KF. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 1988 19:358 65.
12. Morris AJ, Malbon CC. Physiological regulation of G protein-linked signaling. Physiol Rev 1999 79:1373 430.
13. Kumazawa T, Mizumura K, Koda H, Fukusako H. EP receptor subtypes implicated in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat. J Neurophysiol 1996 75:2361 8.
14. Rush AM, Waxman SG. PGE2 increases the tetrodotoxin-resistant Nav1.9 sodium current in mouse DRG neurons via G-proteins. Brain Res 2004 1023:264 71.
15. Zhang YQ, Gao X, Zhang LM, Wu GC. The release of serotonin in rat spinal dorsal horn and periaqueductal gray following carrageenan inflammation. Neuroreport 2000 11:3539 43.
16. Basbaum AI, Jessel TM. The perception of pain. In:Kandel ER, Schwartz JH, Jessel TM, eds. Principles of Neural Science, 4th edn. New York:McGraw-Hil, 2000:472 90.
17. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 1983 16:109 10.
18. Winter WD, Risley E, Nuss GW. Carrageenan-induced edema in hind paw of rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962 111:544 7.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 2001 25:402 8.
20. Chetsawang B, Casalotti SO, Phansuwan-Pujito P, Kotchabhakdi N, Govitrapong P. Gene expressions of opioid receptors and G-proteins in pineal glands. Biochem Biophys Res Commun 1999 262:775 80.
21. Kaewsuk S, Hutamekalin P, Ketterman AJ, Khotchabhakdi N, Govitrapong P, Casalotti SO. Morphine induces short-lived changes in G-protein gene expression in rat prefrontal cortex. Eur J Pharmacol 2001 411:11 6.
22. Honore P, Buritova J, Besson JM. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord the effects of indomethacin. Eur J Pharmacol 1995 272:249 59.
23. Draisci G, Iadarola MJ. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol Brain Res 1989 6:31 7.
24. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In:Wall PD, Melzack R, eds. Textbook of Pain, 4th edn. Edinburgh:Churchill Livingstone, 1999:309 29.
25. Russell NJW, Schaible HG, Schmidet RF. Opiates inhibit the discharges of fine afferent units from inflamed knee joint of the cat. Neurosci Lett 1987 76:107 12.
26. Yaksh TL. Substance P release knee joint afferent terminals: modulation by opioids. Brain Res 1988 458:319 24.
27. Herlitze S, Hockerman GH, Scheuer T, Catterall WA. Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel alpha1A subunit. Proc Natl Acad Sci U S A 1997 94:1512 6.
28. Vaughan CW, Bagley EE, Drew GM et al. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol 2003 139:362 7.
29. Reuveny E, Slesinger PA, Inglese J et al. Activation of the cloned muscarinic potassium channel by G protein beta gamma subunits. Nature 1994 370:143 6.